AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AAC.01595-07v1
52/4/1506    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Gomez-Lopez, A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gomez-Lopez, A.
Antimicrobial Agents and Chemotherapy, April 2008, p. 1506-1509, Vol. 52, No. 4
0066-4804/08/$08.00+0     doi:10.1128/AAC.01595-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Prevalence and Susceptibility Profile of Candida metapsilosis and Candida orthopsilosis: Results from Population-Based Surveillance of Candidemia in Spain{triangledown}

A. Gomez-Lopez,1 A. Alastruey-Izquierdo,1 D. Rodriguez,2 B. Almirante,2 A. Pahissa,2 J. L. Rodriguez-Tudela,1 M. Cuenca-Estrella,1* and the Barcelona Candidemia Project Study Group

Servicio de Micología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain,1 Servicio de Enfermedades Infecciosas, Hospital Universitari Vall d'Hebrón, Universitat Autonoma de Barcelona, Spain2

Received 11 December 2007/ Returned for modification 10 January 2008/ Accepted 6 February 2008

We describe the prevalences and susceptibility profiles of two recently described species, Candida metapsilosis and Candida orthopsilosis, related to Candida parapsilosis in candidemia. The prevalences of these species (1.7% for C. metapsilosis and 1.4% for C. orthopsilosis) are significant. Differences observed in their susceptibility profiles could have therapeutic importance.

* Corresponding author. Mailing address: Servicio de Micología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Ctra Majadahonda-Pozuelo Km 2, 28220 Majadahonda, Madrid, Spain. Phone: 34-91-8223661. Fax: 34-91-5097966. E-mail: mcuenca-estrella{at}isciii.es

{triangledown} Published ahead of print on 19 February 2008.

Antimicrobial Agents and Chemotherapy, April 2008, p. 1506-1509, Vol. 52, No. 4
0066-4804/08/$08.00+0     doi:10.1128/AAC.01595-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.